Literature DB >> 11001938

Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.

R Herrmann1, V Straub, M Blank, C Kutzick, N Franke, E N Jacob, H G Lenard, S Kröger, T Voit.   

Abstract

Limb girdle muscular dystrophy is a group of clinically and genetically heterogeneous disorders inherited in an autosomal recessive or dominant mode. Caveolin-3, the muscle-specific member of the caveolin gene family, is implicated in the pathogenesis of autosomal dominant limb girdle muscular dystrophy 1C. Here we report on a 4-year-old girl presenting with myalgia and muscle cramps due to a caveolin-3 deficiency in her dystrophic skeletal muscle as a result of a heterozygous 136G-->A substitution in the caveolin-3 gene. The novel sporadic missense mutation in the caveolin signature sequence of the caveolin-3 gene changes an alanine to a threonine (A46T) and prevents the localization of caveolin-3 to the plasma membrane in a dominant negative fashion. Caveolin-3 has been suggested to interact with the dystrophin-glycoprotein complex, which in striated muscle fibers links the cytoskeleton to the extracellular matrix and with neuronal nitric oxide synthase. Similar to dystrophin-deficient Duchenne muscular dystrophy, a secondary decrease in neuronal nitric oxide synthase and alpha-dystroglycan expression was detected in the caveolin-3-deficient patient. These results implicate an important function of the caveolin signature sequence and common mechanisms in the pathogenesis of dystrophin-glycoprotein complex-associated muscular dystrophies with caveolin-3-deficient limb girdle muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001938     DOI: 10.1093/oxfordjournals.hmg.a018926

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

Review 1.  Caveolin-deficient mice: insights into caveolar function human disease.

Authors:  B Razani; M P Lisanti
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling.

Authors:  Eva Brauers; Agnes Dreier; Andreas Roos; Berthold Wormland; Joachim Weis; Alexander Krüttgen
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  Post-transcriptional regulation of fukutin in an astrocytoma cell line.

Authors:  Tomoko Yamamoto; Yoichiro Kato; Atsuko Hiroi; Noriyuki Shibata; Makiko Osawa; Makio Kobayashi
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

4.  Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins.

Authors:  Youichi Tajima; Eiichiro Uyama; Shinji Go; Chihiro Sato; Nodoka Tao; Masaharu Kotani; Hirotake Hino; Akemi Suzuki; Yutaka Sanai; Ken Kitajima; Hitoshi Sakuraba
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles.

Authors:  Melissa M Thomas; David C Wang; Donna M D'Souza; Matthew P Krause; Andrew S Layne; David S Criswell; Hayley M O'Neill; Michael K Connor; Judy E Anderson; Bruce E Kemp; Gregory R Steinberg; Thomas J Hawke
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

6.  Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy.

Authors:  Sebahattin Cirak; Florian von Deimling; Shrikesh Sachdev; Wesley J Errington; Ralf Herrmann; Carsten Bönnemann; Knut Brockmann; Stephan Hinderlich; Tom H Lindner; Alice Steinbrecher; Katrin Hoffmann; Gilbert G Privé; Mark Hannink; Peter Nürnberg; Thomas Voit
Journal:  Brain       Date:  2010-06-16       Impact factor: 13.501

7.  Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.

Authors:  David S Park; Scott E Woodman; William Schubert; Alex W Cohen; Philippe G Frank; Madhulika Chandra; Jamshid Shirani; Babak Razani; Baiyu Tang; Linda A Jelicks; Stephen M Factor; Louis M Weiss; Herbert B Tanowitz; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

8.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.

Authors:  Daniel Beltrán-Valero de Bernabé; Sophie Currier; Alice Steinbrecher; Jacopo Celli; Ellen van Beusekom; Bert van der Zwaag; Hülya Kayserili; Luciano Merlini; David Chitayat; William B Dobyns; Bru Cormand; Ana-Elina Lehesjoki; Jesús Cruces; Thomas Voit; Christopher A Walsh; Hans van Bokhoven; Han G Brunner
Journal:  Am J Hum Genet       Date:  2002-10-04       Impact factor: 11.025

9.  Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice.

Authors:  Kwame Hoyte; Vianney Jayasinha; Bing Xia; Paul T Martin
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.